Trust appoints new non-executive directorNick Gash has been appointed to the board of Imperial College Healthcare NHS Trust as a non-executive director and will chair the audit committee. He will also be part of the board in common overseeing all four acute NHS trusts in north west London.
Nick has a wide range of leadership experience, including as chief executive of the National Union of Students and running a successful public affairs consultancy. He has served in various roles on boards and committees within the NHS and was previously a non-executive director at Chelsea and Westminster Hospital NHS Foundation Trust.
The board in common was established in September to strengthen collaborative decision-making across the four trusts that make up the North West London Acute Provider Collaborative. It is also intended to help make the most effective use of their collective resources in order to provide better care, for more people, more fairly. The acute provider collaborative is made up of Chelsea and Westminster Hospital NHS Foundation Trust, The Hillingdon Hospitals NHS Foundation Trust, Imperial College Healthcare NHS Trust and London North West University Healthcare NHS Trust.
Matthew Swindells, who chairs the Trust board and the board in common, said: "I'm delighted to welcome Nick to Imperial College Healthcare. He brings a huge amount of knowledge and expertise to the Trust and the wider collaborative at a key time in our development.”
Find out more about the Trust board and the board in common on our website.
More about Nick
Nick has also recently been appointed a non-executive director of The Hillingdon Hospitals NHS Foundation Trust. Nick has extensive leadership experience, including as chief executive of the National Union of Students and running a successful public affairs consultancy.
He served as chair of West Middlesex University Hospital NHS Trust until its incorporation with Chelsea and Westminster Hospital NHS Foundation Trust in 2015. He continued as a non-executive director for Chelsea and Westminster until 2022, chairing its audit and risk committee. He is also chair of the Royal Society of Medicine’s audit and risk committee.